This update refreshes the evidence library with newly reviewed research and trial information. • New research summaries for semaglutide, tirzepatide, and abaloparatide, with clear study limitations. • Updated trial details for retatrutide, eloralintide, and brenipatide. • New source links and accurate review dates that distinguish recent checks from older references. Peptide Clarity provides educational information, not medical advice or treatment recommendations.

More clarity behind every profile. • Explore a new searchable Evidence Glossary with plain-language explanations of study types, evidence strength, and uncertainty. • Report a library issue directly from a profile. Choose the topic, add an optional source and note, then preview exactly what you share. • See clearer source-check dates and coverage, with publication dates distinguished from editorial checks. • Find the glossary from the Library, a profile, or Settings, with support for larger text sizes. • Dismiss the keyboard more easily when preparing a clinician report. Peptide Clarity remains an educational library and private record-keeping tool, not medical advice.

A fresh review of the evidence behind your library. • Re-reviewed all 91 library profiles against available primary sources. • Updated selected profiles with recent research and clearer explanations of study limitations. • Clarified product-specific approved uses, age restrictions, and safety information. • Corrected study details and improved supporting references. Research findings remain clearly distinguished from approved uses. Peptide Clarity is an educational library and private record-keeping tool, not medical advice.

Look closer at the evidence with the new Evidence Lens. • Explore the study types behind each library profile, with clear explanations of what they do—and do not—establish. • Filter research claims while keeping safety information and uncertainty accessible. • Open “Behind the claim” to see the references attached to each specific claim. • Enjoy clearer filter transitions and improved accessibility layouts. Peptide Clarity is an educational library and private record-keeping tool, not medical advice.

This update improves library clarity and everyday record keeping. - Expanded the library to 91 profiles, including clearly labeled non-peptide references. - Added FDA product-quality warnings and refreshed source references. - Improved library search for alternate names and catalog terms, with clear limits on product identification. - Fixed repeated pause/resume history and final-day reporting for personal schedules. - Preserved unfinished entries when switching apps with App Lock turned off. Peptide Clarity is an educational library and private record-keeping tool, not medical advice.

This update refreshes the educational library and its source references. • Updated human-insulin information and reviewed current trial records. • Added recent retatrutide research with clear distinctions between exploratory findings and proven outcomes. • Refined source dates and evidence context. Peptide Clarity is an educational library and private record-keeping tool, not medical advice.

Peptide Clarity 1.1.0 brings a clearer, more polished experience: • Expanded the cited library to 89 profiles, with updated research and safety context. • Improved searches for alternate names and peptide blends, with clear ingredient-level evidence notices. • Refined the preview, library, daily records, and progress screens with cleaner layouts and subtle animations. • Improved large-text accessibility, onboarding, and subscription navigation. • Added usability and reliability improvements throughout the app. Peptide Clarity is an educational library and private record-keeping tool, not medical advice.

This update makes Peptide Clarity clearer and more reliable: • Updated library references, research summaries, safety information, and compound names. • Improved library search and navigation at larger text sizes. • More reliable number entry and editing for personal records and check-ins. • Clearer progress charts with readable date labels. • Improved accessibility for subscription information and legal links. Peptide Clarity is an educational library and private record-keeping tool, not medical advice.

Peptide Clarity now keeps subscription offers aligned with App Store-localized pricing and improves consistency throughout the purchase flow. This update also includes verification, reliability, and presentation refinements.

Peptide Clarity now explains the value of full access before showing subscription plans. The peptide library has been reviewed against current authoritative sources through August 30, 2026, with citation dates refreshed. This update also adds a direct App Store rating option and includes visual, accessibility, and consistency improvements.

Peptide Clarity 1.0.6 refreshes the cited library through August 27, 2026. This update rechecks all 85 profiles, 345 evidence claims, and 133 citations against current FDA, DailyMed, ClinicalTrials.gov, and PubMed records. It also reconciles the latest label metadata for Forteo, testosterone gel, and Factrel, with minor quality and consistency refinements throughout the library.

Peptide Clarity 1.0.5 refreshes the App Store experience with new screenshots from the latest build, highlighting the expanded 85-profile cited library, clearer evidence profiles, private tracking, daily records, progress trends, iCloud sync, and clinician-ready PDF reports. This update also includes minor quality and presentation refinements.

Peptide Clarity 1.0.4 expands the cited educational library to 85 profiles and refreshes the core experience with clearer evidence summaries, more polished profile cards, improved dashboard overviews, and a more informative subscription preview. This update also refreshes source metadata, improves search coverage for alternate names and blends, and strengthens guarded persistence checks for private personal records.

Expanded to 84 cited profiles, improved alternate-name and blend search, and refreshed the paid preview to explain premium features.

Expanded the curated peptide and GLP-1 library with clearer evidence and regulatory context. Added a white-and-purple light appearance, refined Today and personal tracking, improved progress tools and animations, and strengthened iCloud sync visibility, privacy controls, and reliability.

Expanded the curated peptide and GLP-1 library with duplicate-safe aliases and clearer evidence context. Added a white-and-purple light appearance alongside the original dark theme. Refined Today, personal tracking, progress, navigation, and smooth reduced-motion-aware animations. Improved iCloud sync visibility, privacy controls, and reliability.